hexahydrofarnesyl acetate | 99624-94-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: hexahydrofarnesyl acetate
• 英文别名: 3,7,11-Trimethyldodecylacetate；3,7,11-trimethyldodecyl acetate
• CAS: 99624-94-9
• 化学式: C₁₇H₃₄O₂
• 分子量: 270.456
• InChiKey: FMIKGNLHOCVXJO-UHFFFAOYSA-N

物化性质

• 沸点：
  295.4±8.0 °C(Predicted)
• 密度：
  0.861±0.06 g/cm3(Predicted)
• 保留指数：
  1850

计算性质

• 辛醇/水分配系数(LogP)：
  6.6
• 重原子数：
  19
• 可旋转键数：
  12
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.94
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  hexahydrofarnesyl acetate 在 hydroxide 作用下， 生成 3,7,11-trimethyl-1-dodecyl stearate
  参考文献：
  名称：

  新型含硫生物标记物2,3-二甲基-5-（2,6,10-三甲基十一烷基）噻吩的鉴定

  摘要：

  通过合成该标准，确认了2,3-二甲基-5-（2,6,10-三甲基十一烷基）噻吩作为某些石油和沉积物提取物的主要成分的鉴定。

  DOI：

  10.1016/s0040-4039(00)95886-6
• 作为产物：
  描述：

  反式,反式-金合欢醇 在 platinum(IV) oxide 氢气 作用下， 以 various solvent(s) 为溶剂， 生成 hexahydrofarnesyl acetate
  参考文献：
  名称：

  新型含硫生物标记物2,3-二甲基-5-（2,6,10-三甲基十一烷基）噻吩的鉴定

  摘要：

  通过合成该标准，确认了2,3-二甲基-5-（2,6,10-三甲基十一烷基）噻吩作为某些石油和沉积物提取物的主要成分的鉴定。

  DOI：

  10.1016/s0040-4039(00)95886-6

文献信息

• Fuel compositions comprising farnesane and farnesane derivatives and method of making and using same
  申请人：Renninger Stephen Neil

  公开号：US20080083158A1

  公开（公告）日：2008-04-10

  A fuel composition comprises farnesane and/or farnesane derivatives and a conventional fuel component selected from diesel fuel, jet fuel, kerosene or gasoline. The farnesane or farnesane derivative can be used as a fuel component or as a fuel additive in the fuel composition. The fuel composition may further comprise a conventional fuel additive. Methods of making and using the fuel composition are also disclosed.

  一种燃料组合物包括法尼烷和/或法尼烷衍生物以及从柴油燃料、喷气燃料、煤油或汽油中选择的传统燃料成分。法尼烷或法尼烷衍生物可以用作燃料成分或燃料组合物中的燃料添加剂。该燃料组合物还可以包括传统燃料添加剂。本文还公开了制备和使用该燃料组合物的方法。
• FUEL COMPOSITIONS COMPRISING FARNESANE AND METHOD OF MAKING AND USING SAME
  申请人：Renninger Stephen Neil

  公开号：US20080098645A1

  公开（公告）日：2008-05-01

  A fuel composition comprises farnesane and/or farnesane derivatives and a conventional fuel component selected from diesel fuel, jet fuel, kerosene or gasoline. The farnesane or farnesane derivative can be used as a fuel component or as a fuel additive in the fuel composition. The fuel composition may further comprise a conventional fuel additive. Methods of making and using the fuel composition are also disclosed.

  一种燃料组合物包括法尼烷和/或法尼烷衍生物以及从柴油燃料、喷气燃料、煤油或汽油中选择的传统燃料成分。法尼烷或法尼烷衍生物可以用作燃料组分或燃料组合物中的燃料添加剂。该燃料组合物还可以包括传统燃料添加剂。还公开了制备和使用该燃料组合物的方法。
• Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes
  申请人：McDaniel C. Steven

  公开号：US20100210745A1

  公开（公告）日：2010-08-19

  Disclosed herein are polymeric materials such as a coating, a plastic, a laminate, a composite, an elastomer, an adhesive, or a sealant; a surface treatment such as a textile finish or a wax; a filler for such a polymeric material or a surface treatment that includes an enzyme such as an esterase (e.g., a lipolytic enzyme, a sulfuric ester hydrolase, an organophosphorus compound degradation enzyme), an enzyme (e.g., a lysozyme, a lytic transglycosylase) that degrades a cell wall and/or a cell membrane component, a biocidal or biostatic peotide, and/or a peptidase. Also disclosed herein are methods of altering a material's property such as service life, flexability, or rigidity, by incorporation of an enzyme into a material capable of being chemically crosslinked by the activity of a lipolytic enzyme, a hydrolase, and/or a urease.

  本文公开了一些聚合材料，如涂层、塑料、层压板、复合材料、弹性体、粘合剂或密封剂；一种表面处理，如纺织品涂层或蜡；一种填料，用于这样的聚合材料或表面处理，其中包括一种酶，如酯酶（例如，脂肪水解酶，硫酸酯水解酶，有机磷化合物降解酶），降解细胞壁和/或细胞膜成分的酶（例如，溶菌酶，裂解转糖基酶），生物杀菌或生物静态肽，以及/或肽酶。本文还公开了通过将酶纳入可通过脂肪水解酶、水解酶和/或脲酶的活性交联材料中来改变材料性能，如使用寿命、柔韧性或刚度的方法。
• Anti-fouling Paints and Coatings
  申请人：Reactive Surfaces LTD

  公开号：US20150191607A1

  公开（公告）日：2015-07-09

  Disclosed herein are polymeric materials such as a coating, a plastic, a laminate, a composite, an elastomer, an adhesive, or a sealant; a surface treatment such as a textile finish or a wax; a filler for such a polymeric material or a surface treatment that includes an enzyme such as an esterase (e.g., a lipolytic enzyme, a sulfuric ester hydrolase, an organophosphorus compound degradation enzyme), an enzyme (e.g., a lysozyme, a lytic transglycosylase) that degrades a cell wall and/or a cell membrane component, a biocidal or biostatic peptide, and/or a peptidase. Also disclosed herein are methods of altering a material's property such as service life, flexability, or rigidity, by incorporation of an enzyme into a material capable of being chemically crosslinked by the activity of a lipolytic enzyme, a hydrolase, and/or a urease.

  本文披露了聚合材料，例如涂层、塑料、层压材料、复合材料、弹性体、粘合剂或密封剂；表面处理，例如纺织品整理或蜡；填充剂，用于这种聚合材料或表面处理，包括酯酶（例如脂肪水解酶、硫酸酯水解酶、有机磷化合物降解酶）的酶，降解细胞壁和/或细胞膜成分的酶（例如溶菌酶、裂解转葡糖苷酶），生物杀菌或生物稳定肽，和/或肽酶。本文还披露了通过将酶并入能够通过脂肪水解酶、水解酶和/或脲酶的活性进行化学交联的材料中，改变材料性能（例如使用寿命、柔韧性或刚度）的方法。
• Method of preparation of stereospecific quinone derivatives
  申请人：Mehta, Dilip

  公开号：EP2868658A1

  公开（公告）日：2015-05-06

  A novel process for the regio- and stereospecific synthesis of polyprenylated quinone derivatives, such as Vitamin K1, K2 and Ubiquinone, has been achieved exploiting dithioacetal-, especially 1,3-dithiane-, mediated Umpolung chemistry which works along a new concept "Inhibiting resonance delocalization (IRD)" to overcome isomerization generated due to delocalization of allylic carbanions on the π-electron cloud of an allylic system. The present novel synthesis of all-trans Vitamins K1, K2 and Ubiquinone is achieved by coupling of a quinone group with a polyprenyl side chain where either of the two moieties may have 1,3-dithiane as a terminal group while undergoing umpolung chemistry. Similarly while coupling two polyprenyl fragments to each other in building of the all-trans side chain. A stereospecific synthesis of vitamin K1 was also achieved along the same synthetic outline using a chiral hexahydrofarnesyl derivative retaining optical and geometrical isomeric properties equivalent to those of the natural K1.

  利用二硫代乙缩醛，特别是 1,3-二硫代乙缩醛介导的 Umpolung 化学，实现了一种新工艺，可进行多烯基醌衍生物（如维生素 K1、K2 和泛醌）的区域和立体特异性合成，该工艺采用了一种新概念 "抑制共振失焦（IRD）"，以克服由于烯丙基体系 π 电子云上的烯丙基碳离子失焦而产生的异构化。本新型全反式维生素 K1、K2 和泛醌的合成是通过醌基与聚丙烯酰基侧链的偶联实现的，在偶联过程中，两个分子中的任何一个都可能以 1,3-二噻烷作为末端基团。同样，在建立全反式侧链的过程中，两个多烯基片段也会相互偶联。按照同样的合成方法，我们还利用一种手性六氢法萘基衍生物实现了维生素 K1 的立体特异性合成，该衍生物保留了与天然 K1 相同的光学和几何异构特性。